Daniel D. L. R.
- Country
- Spain
- Department
- Endocrinology
Research Overview
- Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
- Exposure-Response Study of Siplizumab in Adults with New Onset Type 1 Diabetes: A 12-Month, Randomized, Single-Blind, Placebo-Controlled Trial
- J2A-MC-GZGP A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral Orforglipron Compared With Placebo in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)
Data & Insights
Has run more than one trial at 74 of 545 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in treating obesity and overweight conditions, with particular attention to weight-related comorbidities. Their research explores innovative therapeutic approaches for weight management in adult patients.
- Weight Management
- Obesity-Related Complications
- Metabolic Health
Their work includes evaluation of novel therapeutic agents for weight reduction and metabolic improvement.
Cardiovascular Medicine
The investigator focuses on atherosclerotic cardiovascular disease (ASCVD) prevention and treatment. Their expertise extends to managing cardiovascular risks and preventing major adverse cardiovascular events.
- Cardiovascular Risk Management
- Atherosclerosis Treatment
- Preventive Cardiology
Their research encompasses innovative approaches to reducing cardiovascular mortality and morbidity.
Diabetes Care
The investigator specializes in Type 2 Diabetes Mellitus management, with particular emphasis on cardiovascular outcomes in diabetic patients. Their work involves evaluating therapeutic interventions for diabetes care.
- Diabetes Management
- Cardiovascular Complications
- Therapeutic Innovation
Their research focuses on advancing treatment options for patients with type 2 diabetes and high cardiovascular risk.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.